Abstract
Amyotrophic Lateral Sclerosis (ALS) is a group of neurodegenerative disorders that featured with the death of motor neurons, which leads to loss of voluntary control on muscles. The etiologies vary among different subtypes of ALS, and no effective management or medication could be provided to the patients, with the underlying mechanisms incompletely understood yet. Mutations in human Optn (Optineurin), particularly E478G, have been found in many ALS patients. In this work, we report that NF-κB activity was increased in Optn knockout (Optn−/−) MEF (mouse embryonic fibroblast) cells expressing OPTN of different ALS-associated mutants especially E478G. Inflammation was significantly activated in mice infected with lenti-virus that allowed overexpression of OPTNE478G mutation in the motor cortex, with marked increase in the secretion of pro-inflammatory cytokines as well as neuronal cell death. Our work with both cell and animal models strongly suggested that anti-inflammation treatment could represent a powerful strategy to intervene into disease progression in ALS patients who possess the distinctive mutations in OPTN gene.
Highlights
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that is characterized by the progressive degeneration of motor neurons both in the brain and spinal cord [1]
Multiple mutations in OPTN and its deletion had been found in ALS patients, it remained undetermined the exact causality of the disease
The cloned mutants include OPTNE478G, OPTNR96L, OPTNQ454E, OPTN382_383AGins, OPTNQ398X, OPTNQ165X, OPTN Exon5 along with OPTNE50K, which was commonly mutated in open angle glaucoma, OPTN UBA with a deletion of ubiquitin binding domain(474479aa), OPTN LIR with a deletion of LC3 interaction region(169184aa)
Summary
ALS (amyotrophic lateral sclerosis) is a neurodegenerative disease that is characterized by the progressive degeneration of motor neurons both in the brain and spinal cord [1]. About 10% of ALS cases are transmitted in families. The first genetic mutations affected gene SOD1 found to associate with 1–3% of sporadic ALS, while 5% or more are caused by intronic expansion in C9orf72 [2,3,4]. OPTN (Optineurin) has been identified in patients with family or sporadic ALS. Validating the causality of specific variants remains challenging and yet unachieved [1].
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have